Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MALACHITE INNOVATIONS, INC.

(MLCT)
 SummaryQuotesChartsNewsCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Otc Markets
12/02/2021 12/03/2021 12/06/2021 12/07/2021 12/08/2021 Date
0.3125(c) 0.345(c) 0.34(c) 0.37(c) 0.3605 Last
31 284 24 963 51 701 43 057 14 955 Volume
-3.10% +10.40% -1.45% +8.82% -2.57% Change
More quotes
Estimated financial data (e) (USD)
Sales 2020 - - -
Net income 2020 -4,37 M - -
Net cash position 2020 2,27 M - -
P/E ratio 2020 -0,35x
Yield 2020 -
Sales 2021 - - -
Net income 2021 -0,88 M - -
Net cash position 2021 0,85 M - -
P/E ratio 2021 -10,4x
Yield 2021 -
Capitalization 18,5 M 18,5 M -
EV / Sales 2020 -
EV / Sales 2021 -
Nbr of Employees 3
Free-Float 66,9%
More Financials
Company
Malachite Innovations, Inc, formerly Vitality Biopharma, Inc., is a biopharmaceutical company. The Company is focused on developing the cannabinoid pharmaceutical prodrugs also known as cannabosides. The Company utilizes its enzymatic bioprocessing technologies to discover its cannabosides are cannabinoid-glycoside prodrugs. The CompanyÔÇÖs cannabosides products include glycosylated tetrahydrocannabinol (THC),... 
More about the company
All news about MALACHITE INNOVATIONS, INC.
11/15MALACHITE INNOVATIONS, INC. Management's Discussion and Analysis of Financial Conditio..
AQ
11/15Malachite Innovations, Inc. Reports Earnings Results for the Second Quarter and Six Mon..
CI
10/12VITALITY BIOPHARMA : ADOPTS NEW NAME – MALACHITE INNOVATIONS, INC - Form 8-K
PU
10/12VITALITY BIOPHARMA, INC. : Entry into a Material Definitive Agreement, Amendments to Artic..
AQ
10/12VITALITY BIOPHARMA : Adopts New Name – Malachite Innovations, Inc.
GL
10/12Malachite Innovations, Inc. Announces Fiscal Year Change
CI
10/12Malachite Innovations, Inc. Announces Change of Corporate Headquarters
CI
10/12Malachite Innovations, Inc. has Changed its Ticker to MLCT from VBIO
CI
09/02Vitality Biopharma Announces Effective S-1 Registration Statement and DTC Eligibility
GL
09/02VITALITY BIOPHARMA : ANNOUNCES EFFECTIVE S-1 REGISTRATION STATEMENT AND DTC ELIGIBILITY (F..
PU
09/02VITALITY BIOPHARMA, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
08/23VITALITY BIOPHARMA : Enters into $5 million equity financing relationship with institution..
AQ
08/20VITALITY BIOPHARMA : ENTERS INTO $5 MILLION EQUITY LINE FINANCING RELATIONSHIP WITH INSTIT..
PU
08/20VITALITY BIOPHARMA, INC. : Entry into a Material Definitive Agreement, Other Events, Finan..
AQ
08/20Vitality Biopharma Enters Into $5 Million Equity Line Financing Relationship With Insti..
GL
More news
News in other languages on MALACHITE INNOVATIONS, INC.

- No features available -

More news
Chart MALACHITE INNOVATIONS, INC.
Duration : Period :
Malachite Innovations, Inc. Technical Analysis Chart | MLCT | US56089M1071 | MarketScreener
Income Statement Evolution
Managers and Directors
Michael Cavanaugh Chief Executive Officer & Director
Richard McKilligan Controller, Chief Financial & Accounting Officer
Edward F. Feighan Executive Chairman
Brandon Zipp Chief Science Officer
Richard F. Celeste Independent Director
Sector and Competitors
1st jan.Capi. (M$)
MALACHITE INNOVATIONS, INC.516.67%19
GILEAD SCIENCES, INC.19.55%87 368
BIONTECH SE243.27%73 106
REGENERON PHARMACEUTICALS31.46%66 402
WUXI APPTEC CO., LTD.24.26%63 075
VERTEX PHARMACEUTICALS-13.17%52 178